U.S. Personal Products Stock News

NYSE:BRK.B
NYSE:BRK.BDiversified Financial

Berkshire Hathaway BRK.B Valuation Check As Short Term Momentum Cools And Long Term Returns Stay Positive

How Berkshire Hathaway stock has been trading Berkshire Hathaway (BRK.B) has seen relatively muted short term moves, with the stock roughly flat over the past week and posting a gain of about 3% over the past month. Over longer periods, the picture is mixed. The stock has declined about 4% in the past 3 months and about 2% over the past year, while total return over 3 and 5 years remains clearly positive. See our latest analysis for Berkshire Hathaway. At a share price of US$478.63, Berkshire...
NYSE:ESTC
NYSE:ESTCSoftware

Evaluating Elastic (ESTC) After Earnings Beat And AI Momentum Shift Its Valuation

Elastic (ESTC) is back in focus after its latest earnings, where the company moved from a loss to profitability and reported higher revenue, supported by AI powered search, observability, security and multi year contracts. See our latest analysis for Elastic. That earnings beat and guidance have helped the stock regain some ground, with a 30 day share price return of 29.8% and a 90 day share price return of 21.1%, although the 1 year total shareholder return is still down 24.6% and longer...
NYSE:BLK
NYSE:BLKCapital Markets

Is BlackRock’s HPS Redemption Cap Reshaping the Investment Case for Its Private Credit Ambitions (BLK)?

Recently, BlackRock capped investor withdrawals from its approximately US$26.00 billion HPS Corporate Lending Fund at 5% of shares, below requested levels, to manage liquidity against the longer-term nature of its private credit loans and ease pressure on the fund’s structure. This move has intensified attention on liquidity management and risk in private credit vehicles, raising questions about how BlackRock balances investor access with the realities of less liquid, higher-yielding assets...
NYSE:ALSN
NYSE:ALSNMachinery

Is It Time To Reassess Allison Transmission Holdings (ALSN) After Its Recent Share Price Swings

If you are wondering whether Allison Transmission Holdings at around US$118 a share still offers value, the starting point is understanding what the current price is really baking in. The stock has been volatile recently, with a 4.3% gain over the last week, a 7.1% decline over the last month, and returns of 19.6% year to date and 16.8% over the past year that may catch your eye. These moves sit against a backdrop of ongoing interest in capital goods companies and how investors are pricing...
NYSE:SSB
NYSE:SSBBanks

Assessing SouthState Bank (SSB) Valuation After A Weaker Quarter And Rising Regional Banking Pressures

Q1 miss puts SouthState Bank (SSB) under closer investor scrutiny SouthState Bank (SSB) recently reported a softer quarter, missing analyst expectations for revenue and net interest income, and the stock has slipped 3.4% since the release. The weaker print arrives as regional banks contend with fintech competition, deposit outflows, credit quality concerns, and higher regulatory costs. This keeps investors focused on how efficiently each bank manages earnings and balance sheet risk. See our...
NasdaqCM:PLSE
NasdaqCM:PLSEMedical Equipment

Does Pulse Biosciences’ (PLSE) Insider Buying Reinforce Canaccord’s Cardiac PFA Thesis or Raise New Questions?

Earlier this week, Canaccord Genuity initiated coverage on Pulse Biosciences with a buy rating, highlighting its nanosecond pulsed field ablation platform for cardiac applications and its potential for meaningful commercial adoption. In a parallel development, top executives acquired a combined 675,233 shares via the company’s at-the-market equity offering program, underscoring insider confidence in the technology’s commercial prospects. Next, we’ll examine how Canaccord Genuity’s backing of...
NasdaqGM:SPWR
NasdaqGM:SPWRElectrical

SunPower (SPWR) Valuation Check As Stock Settled Interest Plan Seeks Greater Financial Flexibility

SunPower’s equity and debt moves SunPower (SPWR) has moved to close a US$40.7 million shelf registration and is now seeking to pay upcoming interest on its 2029 convertible notes in stock plus bonus shares instead of cash. This combination of equity capacity, proposed share-based interest payments, and a recent incremental investment from Fortis Capital is intended to give the company more room to manage liquidity through Q3 2026. See our latest analysis for SunPower. Recent announcements...
NasdaqGS:DDOG
NasdaqGS:DDOGSoftware

Is It Too Late To Consider Datadog (DDOG) After Its Recent Share Price Surge?

If you are wondering whether Datadog's share price still makes sense after a strong run, the key question is how that price compares with what the business might be worth. The stock last closed at US$243.60, with returns of 8.2% over 7 days, 67.2% over 30 days, 82.1% year to date, 100.1% over 1 year, 153.7% over 3 years and 157.8% over 5 years. That performance naturally raises questions about how much future performance is already reflected in the price. Recent attention on Datadog has...
NYSE:CRL
NYSE:CRLLife Sciences

Can Charles River’s Portfolio Divestitures and “Pathway to Purpose” Strategy Reframe the CRL Investment Narrative?

Charles River Laboratories International recently presented at the William Blair Growth Stock Conference in Chicago and the Jefferies Global Healthcare Conference in New York, outlining its current strategic focus, business developments, and recent trends via live and archived webcasts for investors. These appearances highlighted CEO Birgit Girshick’s new “Pathway to Purpose” framework and ongoing portfolio reshaping, including divestitures of CDMO, Cell Solutions, and selected European...
NYSE:AESI
NYSE:AESIEnergy Services

Atlas Energy Solutions (AESI) Is Up 7.2% After Power Deal With Caterpillar And Convertible Notes Offering

Earlier this week, Raymond James upgraded Atlas Energy Solutions from Market Perform to Outperform after the company reported first-quarter 2026 results and detailed expanded distributed power growth plans, including a global framework agreement with Caterpillar for 1.4 GW of power capacity and a US$450 million convertible senior notes offering to fund expansion toward 2 GW. The upgrade underscores how Atlas is increasingly being viewed not just as a Permian proppant and logistics provider,...
NYSE:CAG
NYSE:CAGFood

Do Inflation Pressures and Dividend Strains Hint at a Deeper Shift in Conagra’s (CAG) Strategy?

In recent days, Conagra Brands reported quarterly results with slightly lower year-over-year revenue that still exceeded analyst expectations, alongside mixed profit guidance affected by commodity cost pressures. At the same time, several analysts warned that persistent inflation and a high payout ratio could put Conagra’s dividend policy under scrutiny, even as insiders accepted additional equity awards. We’ll now examine how concerns about inflation-driven cost pressures and potential...
NYSE:PINS
NYSE:PINSInteractive Media and Services

A Look At Pinterest (PINS) Valuation After Its $4 Billion AWS AI Infrastructure Deal

Why Pinterest’s $4 Billion AWS Deal Matters for the Stock Pinterest (PINS) has committed US$4b to Amazon Web Services through 2031, its largest infrastructure agreement to date, to support AI model development, faster search and shopping, and global platform modernization. See our latest analysis for Pinterest. The AWS commitment lands after a volatile stretch for Pinterest, with the share price up 4.5% over the past week and 7.9% over 90 days, yet down 18.7% year to date and a 36.1% total...
NasdaqGS:ELVN
NasdaqGS:ELVNPharmaceuticals

Assessing Enliven Therapeutics (ELVN) Valuation As Investors Await Phase 1 ELVN-001 Data And Analyst Support

Clinical data catalyst and recent stock move Enliven Therapeutics (ELVN) is back in focus after the company highlighted upcoming Phase 1 ENABLE trial data for ELVN-001 in chronic myeloid leukemia, set to be presented at the European Hematology Association Congress. The company plans a June 11 webcast to walk through the updated results. This, together with recent positive analyst commentary, has drawn fresh attention to a stock that is up 66.1% over the past year. See our latest analysis for...
NYSE:BAP
NYSE:BAPBanks

Record Dividend And 21.1% ROE Could Be A Game Changer For Credicorp (BAP)

Recently, Credicorp reported a strong first quarter with a 21.1% return on equity and declared a record dividend of 50 soles per share, citing robust solvency and confidence in its business trajectory. The company’s dividend yield now stands well above industry and S&P 500 averages, underpinned by several years of dividend growth and earnings that analysts view as supportive of ongoing payouts. Next, we’ll examine how Credicorp’s record dividend and solid first-quarter profitability...
NasdaqGS:QLYS
NasdaqGS:QLYSSoftware

Assessing Qualys (QLYS) Valuation After Recent Share Price Gains And Renewed Cybersecurity Interest

Recent price moves and renewed interest in Qualys Recent gains in Qualys (QLYS) have drawn fresh attention, as the stock rose 11.1% over the past week and 21.0% over the past month, even as longer term returns remain weaker. This move comes as some valuation models suggest the shares trade below certain fair value estimates. This has prompted some investors to reassess the cybersecurity and cloud-based security provider's positioning within their portfolios. See our latest analysis for...
NasdaqGS:AGIO
NasdaqGS:AGIOBiotechs

Why Agios Pharmaceuticals (AGIO) Is Down 5.4% After Overhauling Its Hematology Portfolio - And What's Next

In late May and early June 2026, Agios Pharmaceuticals halted development of tebapivat in lower-risk myelodysplastic syndromes, gained European Commission approval for PYRUKYND (mitapivat) in thalassemia across all EU member states, and licensed exclusive global rights to cevidoplenib, an oral SYK inhibitor, from Oscotec for immune thrombocytopenia and other indications. Together, these updates reshape Agios’s mix of commercial products and pipeline assets, trading one unpromising program...
NYSE:AERO
NYSE:AEROAirlines

Grupo Aeroméxico’s Record Sales Test Discounted Valuation And Balance Sheet Risks

Grupo Aeroméxico, listed as NYSE:AERO, reported record weekly sales in May 2026, the highest in the company’s history. The record sales coincided with growing passenger traffic for May 2026 across both international and domestic routes. The update points to strong travel demand and a meaningful shift in recent operating activity for the airline. For you as an investor, this update reinforces Grupo Aeroméxico’s position as a major Mexican carrier with meaningful exposure to both domestic and...
NYSE:AON
NYSE:AONInsurance

What Aon (AON)'s Leadership Refresh and AI Risk Push Mean For Shareholders

Aon has recently strengthened its leadership bench, appointing Alberto Carrion as head of Lenders Solutions, Helene Madell as chief executive of its Global Broking Centre, and Herlina Surya as a power adviser in Indonesia, while also publishing new insights on AI-driven human capital trends and rising M&A transaction insurance claims. Together, these moves highlight Aon’s focus on complex risk advisory, middle-market and infrastructure clients, and fast-evolving workforce and AI-related...
NYSE:GBX
NYSE:GBXMachinery

How Investors May Respond To Greenbrier Companies (GBX) Revenue Miss And Weaker Full-Year Guidance

In the past few days, Greenbrier Companies reported quarterly results showing a 22.9% year-on-year revenue drop and revenue falling 11.5% short of analyst expectations, alongside weaker full-year revenue and EPS guidance than previously anticipated. This combination of softer current performance and a more cautious outlook has raised fresh questions about how resilient Greenbrier’s railcar and leasing businesses may be against industry headwinds and cost pressures. Next, we’ll examine how...
NasdaqGS:MCHP
NasdaqGS:MCHPSemiconductor

Is It Too Late To Consider Microchip Technology (MCHP) After Its 48% Year To Date Surge?

If you are wondering whether Microchip Technology at around US$96.30 is still offering value or if the easier gains are behind it, this breakdown will help you weigh what the current price really implies. The stock is roughly flat over the past week with a 0.3% gain, a little softer over the last month with a 2.2% decline, yet stands out with returns of 48.1% year to date and 53.7% over the past year. Recent coverage has focused on Microchip Technology's role within the broader semiconductor...
NYSE:TDY
NYSE:TDYElectronic

Assessing Teledyne Technologies (TDY) Valuation After New Defense Contract And Space Semiconductor Launch

Teledyne Technologies (TDY) has been back in focus after Teledyne FLIR Defense secured an $11.2 million U.S. Army contract for advanced CBRN drone kits and Teledyne HiRel Semiconductors introduced a new space qualified low noise amplifier. See our latest analysis for Teledyne Technologies. Despite a modest 1-day share price return of 0.09% and recent share price softness over the past quarter, Teledyne Technologies still carries a 19.24% year to date share price return and a 23.71% 1-year...
NYSE:OMF
NYSE:OMFConsumer Finance

OneMain’s 2026 Consumer Loan ABS Deal Adds Funding And Valuation Insight

OneMain Holdings (NYSE:OMF) has launched its first consumer loan asset backed securities securitization of 2026. This transaction is the company's 32nd consumer loan ABS issuance since 2013. The new deal has attracted ratings coverage, adding a fresh data point for investors tracking OneMain's funding mix. For investors watching consumer finance, OneMain sits at the intersection of personal lending and structured credit. The company uses consumer loan ABS as a recurring funding tool. The...
NYSE:VEEV
NYSE:VEEVHealthcare Services

Veeva Systems (VEEV) Net Margin Improvement Tests Bullish Long‑Term Targets

Veeva Systems (VEEV) kicked off Q1 2027 with revenue of US$882.9 million and basic EPS of US$1.60, against a backdrop of trailing 12 month EPS of US$5.75 and total revenue of about US$3.3 billion that has been reported growing around 11.2% year over year. Over recent quarters, revenue has moved from US$759.0 million in Q1 2026 through US$835.9 million in Q4 2026 to US$882.9 million in Q1 2027, while basic EPS has shifted from US$1.40 to US$1.49 and then to US$1.60 over the same period,...